Comparative Analysis of Retroviral Promoters for Reporter gene Imaging of T cell Immunotherapy - PowerPoint PPT Presentation

Loading...

PPT – Comparative Analysis of Retroviral Promoters for Reporter gene Imaging of T cell Immunotherapy PowerPoint presentation | free to download - id: 6ed896-YmJjN



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Comparative Analysis of Retroviral Promoters for Reporter gene Imaging of T cell Immunotherapy

Description:

Comparative Analysis of Retroviral Promoters for Reporter gene Imaging of T cell Immunotherapy By: Dario Pinos, Jason Lee PhD Image courtesy of Live Science. – PowerPoint PPT presentation

Number of Views:36
Avg rating:3.0/5.0
Slides: 17
Provided by: Admini583
Learn more at: http://www.ccny.cuny.edu
Category:

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Comparative Analysis of Retroviral Promoters for Reporter gene Imaging of T cell Immunotherapy


1
Comparative Analysis of Retroviral Promoters for
Reporter gene Imaging of T cell Immunotherapy
  • By Dario Pinos, Jason Lee PhD

Image courtesy of Live Science. Retrieved from
http//www.livescience.com/16752-gfp-protein-fluor
escent-nih-nigms.html
2
Acknowledgments
  • CCNY-MSKCC Partnership for Cancer Research
  • Dr. Karen Hubbard Principle Investigator
  • Nadia Noman Training Director
  • Leo Spychala Administrative Assistant
  • This research was supported by NIH/NCI
    U54CA132378.
  • Thank you to my mentors, Jason Lee, PhD and
    Vladimir Ponomarev, MD, Ph.D (MSKCC), Juan Zurita
    (MSKCC), Nikita Suzmin (MSKCC) and Sheila
    Fortunato (MSKCC) for their guidance and
    assistance in this project.

3
Introduction
  • What methods are there for treating Cancer?
  • The most prominent and familiar treatments for
    cancer would be through the use of radioactive
    materials and cytotoxic drugs, radiation and
    chemotherapy, respectively. Another process that
    is being more heavily researched would be
    Immunotherapy.

Image courtesy of New Hope Medical Center.
Retrieved from http//www.newhopemedicalcenter.co
m/case-studies
4
Introduction (contd)
  • Immunotherapy is the treatment or prevention of
    disease through the manipulation of the immune
    system. For our purposes, we seek to use
    molecular imaging methods to track T cell
    activity for enhanced cancer immunotherapy.

Image courtesy of Synaptic Speculations.
Retrieved from http//www.synapticspeculations.co
m/facts-behind-antibiotic-resistance/
5
Introduction (contd)
  • Why fluorescence?
  • Fluorescence is the emitting of light as a result
    of exposure to a certain wavelength. The benefit
    of using fluorescence is that it provides a
    noninvasive method of tracking T-cell
    activity.1 By being able to attach GFP tags
    onto cells allows us to understand the folding
    process of proteins and other activities. 4

Fluorescent Promoter Excitation Maximum (nm) Emission Minimum (nm) Color of Emission
EGFP 488 509 Green
TurboFP635 588 635 Red
Data above courtesy of Evrogen. Retrieved from
http//www.evrogen.com/products/TurboFP635/TurboFP
635_Detailed_description.shtml
6
How would fluorescence work?
  • In order to track T cell activity through
    fluorescence, an effective tag would have to be
    created through the use of a Vector, which is a
    DNA molecule which is able to transport genetic
    material from one host to another which can then
    be replicated.
  • Dr. Ponomarevs lab had previously created a
    vector called NFAT-exClucTM/GFP
    SV40-tdr/rsRluc or NF97 for short.
  • We seek to create
  • NFAT-exClucTM/GFP SV40-TurboFP635 (NF98)
  • NFAT-exClucTM/GFP PGK-TurboFP635 (NF99)

7
Promoters in Question
  • The promoters to create NF98 and NF99 are SV40
    and PGK, respectively.
  • According to scientific literature, when it comes
    to GFP fluorescence, SV40 consistently performs
    better in resulting fluorescence in mammalian
    cells. 2 3

Image courtesy of Live Science. Retrieved
fromhttp//www.livescience.com/16752-gfp-protein-
fluorescent-nih-nigms.html
8
Figure 1 Above displays the results from
Northeast Normal University, a relationship is
shown between promoter used and the flow
cytometry measurement of GFP fluorescence.
Retrieved from Qin J. et al. Systematic
Comparison of Constitutive Promoters and the
Doxycycline-Inducible Promoter. Plos One 5(5).
Published on May 2010
9
Materials Used
  • Reactants NF97, TurboGFP, HindIII, ASCI, NdeI,
    EcoRI, NheI, dNTP, Klenow polymerase.
  • Buffers NE Buffer 4, NE Buffer 1, BSA, CIP,
    nuclease free dH2O.

Image courtesy of Ross Lippert, retrieved
fromhttp//snhs-plin.barry.edu/cell-biology-lab/R
estriction_Digest_MIT_Lippert.htm
10
Procedure
  • Step 1 Cleaving of NF97 at restriction sites
    with their respective enzyme.
  • Step 2 Gel electrophoresis, isolating desired
    band lengths, gel purification of samples.

Image courtesy of Elderkin Conservation Genetics
Lab. Retrieved from http//www.tcnj.edu/elderkin
/equipment.html
11
Procedure (contd)
  • Step 3 Ligation of the desired DNA bands,
    exposure of the ligation to E. coli, beginning a
    transformation process.
  • Step 4 Purifying DNA plasmid from several
    colonies of E. coli.

Image courtesy of RWTHAachen University.
Retrieved from http//www.biologie.rwth-aachen.de
/
12
Preliminary Results
  • Unfortunately once extracted from the E.coli
    cells, the DNA plasmid created did not have band
    lengths matching those that were predicted.
    However, the bands across 20 samples were fairly
    uniform, meaning the transformation process was
    successful.

Courtesy of the University of Wisconsin.
Retrieved from http//www.jlindquist.net/generalm
icro/GBimages/eaurescens.jpg
13
Preliminary Results (contd)
  • However, once the procedure was repeated with the
    addition of another restriction enzyme to one of
    the reactions, one of the colonies of 48
    displayed the desired band lengths!

14
08-24-2013 NF98 cl18 transfection
293T control
293T NF98(SV40 promoter)
brightfield
GFP
TurboRFP635
15
Future Development
  • Once NF98 is successfully tested, NF99 would be a
    comparatively shorter process to create.
  • The next steps would be to ultimately conduct a
    series of tests such as through transformation in
    mammalian cells to ensure proper orientation of
    the vector.

16
References
  • 1 Ponomarev V. et al. Imaging TCR-Dependent
    NFAT-Mediated T-Cell Activation with Positron
    Emission Tomography In Vivo Neoplasia 3(6)
    pp.480-488. 2001.
  • 2 Qin J. et al. Systematic Comparison of
    Constitutive Promoters and the Doxycycline-Inducib
    le Promoter. Plos One 5(5). Published on May
    2010
  • 3 Liu Q. et al. The Activity of SV40 Promoter
    can be inhibited by Overexpression of Heme
    Oxgenase-1 in Tumor Cells Cell Biochemistry and
    Biophysics. Published on Oct. 23rd 2012.
  • 4 MacLachlan A. How a Jellyfish Protein
    Transformed Science Live Science Retrieved from
    http//www.livescience.com/16752-gfp-protein-fluor
    escent-nih-nigms.html
About PowerShow.com